SynthesisFrontiers in gastroenterology (Lausanne, Switzerland)2025

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis.

Liwei Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.